Unknown

Dataset Information

0

Quantitative systems pharmacology model of GITR-mediated T cell dynamics in tumor microenvironment.


ABSTRACT: T cell interaction in the tumor microenvironment is a key component of immuno-oncology therapy. Glucocorticoid-induced tumor necrosis factor receptor (TNFR)-related protein (GITR) is expressed on immune cells including regulatory T cells (Tregs) and effector T cells (Teffs). Preclinical data suggest that agonism of GITR in combination with Fc-γ receptor-mediated depletion of Tregs results in increased intratumoral Teff:Treg ratio and tumor shrinkage. A novel quantitative systems pharmacology (QSP) model was developed for the murine anti-GITR agonist antibody, DTA-1.mIgG2a, to describe the kinetics of intratumoral Tregs and Teffs in Colon26 and A20 syngeneic mouse tumor models. It adequately captured the time profiles of intratumoral Treg and Teff and serum DTA-1.mIgG2a and soluble GITR concentrations in both mouse models, and described the response differences between the two models. The QSP model provides a quantitative understanding of the trade-off between maximizing Treg depletion versus Teff agonism, and offers insights to optimize drug design and dose regimen.

SUBMITTER: Ji Y 

PROVIDER: S-EPMC10014051 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Quantitative systems pharmacology model of GITR-mediated T cell dynamics in tumor microenvironment.

Ji Yan Y   Madrasi Kumpal K   Knee Deborah A DA   Gruenbaum Lore L   Apgar Joshua F JF   Burke John M JM   Gomes Bruce B  

CPT: pharmacometrics & systems pharmacology 20230206 3


T cell interaction in the tumor microenvironment is a key component of immuno-oncology therapy. Glucocorticoid-induced tumor necrosis factor receptor (TNFR)-related protein (GITR) is expressed on immune cells including regulatory T cells (Tregs) and effector T cells (Teffs). Preclinical data suggest that agonism of GITR in combination with Fc-γ receptor-mediated depletion of Tregs results in increased intratumoral Teff:Treg ratio and tumor shrinkage. A novel quantitative systems pharmacology (QS  ...[more]

Similar Datasets

| S-EPMC7293198 | biostudies-literature
| S-EPMC6765697 | biostudies-literature
| S-EPMC9287616 | biostudies-literature
| S-EPMC6662387 | biostudies-literature
| S-EPMC6531394 | biostudies-literature
| S-EPMC8449028 | biostudies-literature
| S-EPMC2822720 | biostudies-literature
| S-EPMC7877855 | biostudies-literature
| S-EPMC5572374 | biostudies-literature
| S-EPMC8199881 | biostudies-literature